← Back to contracts

Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)

US National Institutes of Health (HHS-NIH) grant open #PAR-25-122
Response due Nov 16, 2027 · 00:00 UTC

Summary

This NIH funding opportunity (PAR-25-122) solicits R03 small research grant applications for pilot projects investigating understudied proteins associated with rare diseases. Clinical trials are explicitly not allowed under this mechanism. The opportunity is open for a multi-year window (October 2024 through November 2027), suggesting multiple submission cycles. It is issued by the National Institutes of Health under the Department of Health and Human Services.

What they want

Technical requirements
  • Clinical trials not allowed
  • R03 small research grant mechanism
  • Research must focus on understudied proteins associated with rare diseases

How they evaluate

Submission: Grants.gov federal grants portal (electronic submission)

Risks & flags

  • Highly specific research focus (understudied proteins + rare diseases) may limit applicant pool to niche academic/research institutions
  • Multi-year open window with rolling submissions is typical for NIH program announcements but may favor established NIH-funded labs with existing infrastructure

Market context

inferred from NAICS
Professional, Scientific & Technical Services
NAICS 541714
US market size
$2.0T
Typical award
$25K – $50M
Typical buyers
All federal civilianDoDStates
Commonly required
8(a)WOSBSDVOSBPE/PMP

Sector-level estimate — full code lookup not yet in catalog.

Pilot Projects Investigating Understudied …
Due Nov 16
Onboard